By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.
Proven
Single dose, safe and high efficacy proven in academic research
Huge Immediate Need
Cancer Related Mental Distress: 15 million
Mental Health Sufferers: ~792 million
Key Milestones for 2023
Pharmacokinetic Study (Phase 1) completion in Q3 2023
Rapid Access
Accelerated clinical deveopment pathways (Real World Evidence)